We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promising Preclinical Results for Compound to Treat Wilson's Disease

News   Jun 28, 2018 | Original story from Cold Spring Harbor Laboratory (CSHL)

 
Promising Preclinical Results for Compound to Treat Wilson's Disease

Liver complications in Wilson's disease include enlarged cell size, irregular shape and arrangement in liver tissue (left image). Treatment with DPM-1001 reversed these pathologies in a Wilson's disease mouse model (right image) and led to dramatic lowering of tissue copper levels. Credit: Tonks Lab, CSHL

 
 
 

RELATED ARTICLES

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

Pre-symptomatic Skin Test for Prion Disease May Replace Brain Biopsy

News

Preclinical detection of prions has proven difficult, but new research suggests skin samples hold early signs of prion disease that precede neurologic symptoms.

READ MORE

Stem Cells Grown in Media Free of Animal-derived Compounds

News

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE